NASDAQ:MIST

Milestone Pharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy MIST

*Your capital is at risk

$1.30

-0.0100 (-0.763%)

At Close: Jun 23, 2026

Milestone Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 17.87. In total, the insiders bought 9.04M and sold 548.08K MIST shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	17.87
● Buy	9.04M shares
● Sell	548.08K shares
86% Buy Activity Negligible or No Correlation
Buy Signal Medium Confidence Feb 02, 2026 Analysis Breakdown: Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (86% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 10, 2026 Buy	Stock Option (right to buy) A-Award	Fischer Seth H. Z. Director	Director	77 000 Value: $93.9K
Jun 10, 2026 Buy	Stock Option (right to buy) A-Award	Giles Lisa M. Director	Director	77 000 Value: $93.9K
Jun 10, 2026 Buy	Stock Option (right to buy) A-Award	Duty Stuart Director	Director	77 000 Value: $93.9K
Jun 10, 2026 Buy	Stock Option (right to buy) A-Award	Wills Robert James Director	Director	77 000 Value: $93.9K
Jun 10, 2026 Buy	Stock Option (right to buy) A-Award	Tomsicek Michael John Director	Director	77 000 Value: $93.9K
Jun 10, 2026 Buy	Stock Option (right to buy) A-Award	Saik Andrew Director	Director	77 000 Value: $93.9K
Jun 10, 2026 Buy	Stock Option (right to buy) A-Award	Papa Joseph C Director	Director	77 000 Value: $93.9K
Apr 16, 2026 Sell	Common Shares S-Sale	Oliveto Joseph President And CEO	CEO / President	36 500 Value: $82.5K
Mar 17, 2026 Buy	Employee Stock Option (right to buy)	Sandoval David I. GC & Chief Compliance Officer	Officer	400 000 Value: $784.0K
Feb 02, 2026 Buy	Employee Stock Option (right to buy) A-Award	Hasija Amit CFO & EVP Of Corp. Development	C-Suite Officer	204 000 Value: $399.8K
Feb 02, 2026 Buy	Employee Stock Option (right to buy) A-Award	Muller Lorenz Chief Commercial Officer	Officer	204 000 Value: $399.8K
Feb 02, 2026 Buy	Employee Stock Option (right to buy) A-Award	Nelson Jeffrey Edward Chief Operating Officer	C-Suite Officer	204 000 Value: $399.8K
Feb 02, 2026 Buy	Employee Stock Option (right to buy) A-Award	Oliveto Joseph President And CEO	CEO / President	679 000 Value: $1.33M
Feb 02, 2026 Buy	Employee Stock Option (right to buy) A-Award	Bharucha David Chief Medical Officer	Officer	204 000 Value: $399.8K
Feb 02, 2026 Buy	Restricted Stock Unit A-Award	Muller Lorenz Chief Commercial Officer	Officer	136 000 Value: $266.6K
Feb 02, 2026 Buy	Employee Stock Option (right to buy) A-Award	Muller Lorenz Chief Commercial Officer	Officer	204 000 Value: $401.9K
Feb 02, 2026 Buy	Employee Stock Option (right to buy) A-Award	Hasija Amit CFO & EVP Of Corp. Development	C-Suite Officer	204 000 Value: $401.9K
Feb 02, 2026 Buy	Restricted Stock Unit A-Award	Hasija Amit CFO & EVP Of Corp. Development	C-Suite Officer	136 000 Value: $266.6K
Feb 02, 2026 Buy	Employee Stock Option (right to buy) A-Award	Nelson Jeffrey Edward Chief Operating Officer	C-Suite Officer	204 000 Value: $401.9K
Feb 02, 2026 Buy	Restricted Stock Unit A-Award	Nelson Jeffrey Edward Chief Operating Officer	C-Suite Officer	136 000 Value: $266.6K
Feb 02, 2026 Buy	Employee Stock Option (right to buy) A-Award	Bharucha David Chief Medical Officer	Officer	204 000 Value: $401.9K
Feb 02, 2026 Buy	Restricted Stock Unit A-Award	Bharucha David Chief Medical Officer	Officer	136 000 Value: $266.6K
Feb 02, 2026 Buy	Employee Stock Option (right to buy) A-Award	Oliveto Joseph President And CEO	CEO / President	679 000 Value: $1.34M
Feb 02, 2026 Buy	Restricted Stock Unit A-Award	Oliveto Joseph President And CEO	CEO / President	453 000 Value: $887.9K
Jan 26, 2026 Buy	Restricted Stock Units M-Exempt	Oliveto Joseph President And CEO	CEO / President	66 600 Value: $129.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT MILESTONE PHARMACEUTICALS INC.

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and ...

Read Full Profile Here